Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Pickles

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2017
The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapyEric Tran, Matthew Paquette, Justin Jay, et al.
Cureus|July 17, 2015
Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate CancerAndrew Warner, Tom Pickles, Juanita Crook, et al.
European Urology|June 23, 2016
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active TreatmentLeonard P Bokhorst, Riccardo Valdagni, Antti Rannikko, et al.
Practical Radiation Oncology|November 16, 2020
Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective ReviewJordan Wong, Tom Pickles, Joseph Connors, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancerLaurence Klotz, Rodney H Breau, Loretta L Collins, et al.
Brachytherapy|March 15, 2011
The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapyChristopher Herbert, W James Morris, Jeremy Hamm, et al.
Cancer|January 19, 2012
Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapyBelinda A Campbell, Joseph M Connors, Randy D Gascoyne, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2009
Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-upMira Keyes, Stacy Miller, Veronika Moravan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 5, 2011
Development of indicators of the quality of radiotherapy for localized prostate cancerBrita Danielson, Michael Brundage, Robert Pearcey, et al.
World Journal of Urology|March 31, 2015
Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS)Hanna Vasarainen, Jolanda Salman, Heidi Salminen, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2017
The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapyEric Tran, Matthew Paquette, Justin Jay, et al.
Cureus|July 17, 2015
Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate CancerAndrew Warner, Tom Pickles, Juanita Crook, et al.
European Urology|June 23, 2016
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active TreatmentLeonard P Bokhorst, Riccardo Valdagni, Antti Rannikko, et al.
Practical Radiation Oncology|November 16, 2020
Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective ReviewJordan Wong, Tom Pickles, Joseph Connors, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancerLaurence Klotz, Rodney H Breau, Loretta L Collins, et al.
Brachytherapy|March 15, 2011
The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapyChristopher Herbert, W James Morris, Jeremy Hamm, et al.
Cancer|January 19, 2012
Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapyBelinda A Campbell, Joseph M Connors, Randy D Gascoyne, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2009
Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-upMira Keyes, Stacy Miller, Veronika Moravan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 5, 2011
Development of indicators of the quality of radiotherapy for localized prostate cancerBrita Danielson, Michael Brundage, Robert Pearcey, et al.
World Journal of Urology|March 31, 2015
Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS)Hanna Vasarainen, Jolanda Salman, Heidi Salminen, et al.
Pageof 14